|
1.
|
DW KampAsbestos-induced lung diseases: an
updateTransl Res153143152200910.1016/j.trsl.2009.01.00419304273
|
|
2.
|
J SchneiderR ArhelgerG
Hauser-HeidtWertigkeit der statischen Compliance-Messung bei
Asbestfaserstaub-verursachten Erkrankungen der Lunge und der
PleuraWissenschaftlicher Abschlußbericht1792006(In German).
|
|
3.
|
CB ManningV VallyathanBT MossmanDiseases
caused by asbestos: mechanisms of injury and disease developmentInt
Immunopharmacol2191200200210.1016/S1567-5769(01)00172-211811924
|
|
4.
|
C DostertV PetrilliR Van BruggenC SteeleBT
MossmanJ TschoppInnate immune activation through Nalp3 inflammasome
sensing of asbestos and
silicaScience320674677200810.1126/science.115699518403674
|
|
5.
|
I AtesB YucesoyA YucelSH SuzenY KarakasA
KarakayaPossible effect of gene polymorphisms on the release of TNF
alpha and IL1 cytokines in coal workers’ pneumoconiosisExp Toxicol
Pathol63175179201120005085
|
|
6.
|
A WeberP WasiliewM KrachtInterleukin-1
(IL-1) pathway (Review)Sci Signal3cm12010
|
|
7.
|
A WeberP WasiliewM KrachtInterleukin-1beta
(IL-1beta) processing pathway (Review)Sci
Signal3cm2201020086236
|
|
8.
|
E VoronovDS ShouvalY KrelinIL-1 is
required for tumor invasiveness and angiogenesisProc Natl Acad Sci
USA10026452650200310.1073/pnas.043793910012598651
|
|
9.
|
Y KrelinE VoronovS
DotanInterleukin-1beta-driven inflammation promotes the development
and invasiveness of chemical carcinogen-induced tumorsCancer
Res6710621071200710.1158/0008-5472.CAN-06-295617283139
|
|
10.
|
DM ElarajDM WeinreichS VargheseThe role of
interleukin 1 in growth and metastasis of human cancer
xenograftsClin Cancer
Res1210881096200610.1158/1078-0432.CCR-05-160316489061
|
|
11.
|
K BhattacharyaE DoppP KakkarBiomarkers in
risk assessment of asbestos exposureMutat
Res579621200510.1016/j.mrfmmm.2005.02.02216112146
|
|
12.
|
MI LusterPP SimeonovaAsbestos induces
inflammatory cytokines in the lung through redox sensitive
transcription factorsToxicol Lett102–103271275199810022265
|
|
13.
|
R ZhaiG LiuX GeSerum levels of tumor
necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and their
soluble receptors in coal workers’ pneumoconiosisRespir
Med96829834200212412984
|
|
14.
|
FA HoussiauJP DevogelaerJ Van DammeCN de
DeuxchaisnesJ Van SnickInterleukin-6 in synovial fluid and serum of
patients with rheumatoid arthritis and other inflammatory
arthritidesArthitis
Rheum31784788198810.1002/art.17803106143260102
|
|
15.
|
PC TrevilattoRM Scarel-CaminagaRB de Brito
JrAP de SouzaSR LinePolymorphism at position −174 of IL-6 gene is
associated with susceptibility to chronic periodontitis in a
Caucasian Brazilian populationJ Clin Periodontol304384422003
|
|
16.
|
RM GrossmanJ KruegerD YourishInterleukin 6
is expressed in high levels in psoriatic skin and stimulates
proliferation of cultured human keratinocytesProc Natl Acad Sci
USA8663676371198910.1073/pnas.86.16.63672474833
|
|
17.
|
J BidwellL KeenG GallagherCytokine gene
polymorphism in human disease: on-line databasesGenes
Immun1319199910.1038/sj.gene.6363645
|
|
18.
|
J BidwellL KeenG GallagherCytokine gene
polymorphism in human disease: on-line databases, supplement 1Genes
Immun26170200110.1038/sj.gene.636373311393658
|
|
19.
|
MV HollegaardJL BidwellCytokine gene
polymorphism in human disease: on-line databases, Supplement 3Genes
Immun7269276200610.1038/sj.gene.636430116642032
|
|
20.
|
SK HallDG PerregauxCA GabelCorrelation of
polymorphic variation in the promoter region of the interleukin-1
beta gene with secretion of interleukin-1 beta proteinArthritis
Rheum5019761983200410.1002/art.2031015188375
|
|
21.
|
F PociotJ MolvigL WogensenH WorsaaeJ
NerupA TaqI polymorphism in the human interleukin-1 beta (IL-1
beta) gene correlates with IL-1 beta secretion in vitroEur J Clin
Invest22396402199210.1111/j.1365-2362.1992.tb01480.x1353022
|
|
22.
|
D FishmanG FauldsR JefferyThe effect of
novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6
transcription and plasma IL-6 levels, and an association with
systemic-onset juvenile chronic arthritisJ Clin
Invest10213691376199810.1172/JCI26299769329
|
|
23.
|
R SabatG GrutzK WarszawskaBiology of
interleukin-10Cytokine Growth Factor
Rev21331344201010.1016/j.cytogfr.2010.09.002
|
|
24.
|
KW MooreR de Waal MalefytRL CoffmanA
O’GarraInterleukin-10 and the interleukin-10 receptorAnnu Rev
Immunol19683765200110.1146/annurev.immunol.19.1.68311244051
|
|
25.
|
A SuarezP CastroR AlonsoL MozoC
GutierrezInterindividual variations in constitutive interleukin-10
messenger RNA and protein levels and their association with genetic
polymorphismsTransplantation75711717200310.1097/01.TP.0000055216.19866.9A
|
|
26.
|
American Thoracic SocietyIdiopathic
pulmonary fibrosis: diagnosis and treatment. International
consensus statement. American Thoracic Society (ATS), and the
European Respiratory Society (ERS)Am J Respir Crit Care
Med161646664200010.1164/ajrccm.161.2.ats3-00
|
|
27.
|
American Thoracic Society/European
Respiratory Society International Multidisciplinary Consensus
Classification of the Idiopathic Interstitial PneumoniasThis joint
statement of the American Thoracic Society (ATS), and the European
Respiratory Society (ERS) was adopted by the ATS board of
directors, June 2001 and by the ERS Executive Committee, June
2001Am J Respir Crit Care
Med165277304200210.1164/ajrccm.165.2.ats01
|
|
28.
|
WD TravisTumours of the Lung, Pleura,
Thymus and HeartIARC PressLyon9562004
|
|
29.
|
KG HeringM JacobsenE Bosch-GaletkeFurther
development of the International Pneumoconiosis Classification -
from ILO 1980 to ILO 2000 and to ILO 2000/German Federal Republic
versionPneumologie575765842003(In German).
|
|
30.
|
BT MossmanA ChurgMechanisms in the
pathogenesis of asbestosis and silicosisAm J Respir Crit Care
Med15716661680199810.1164/ajrccm.157.5.97071419603153
|
|
31.
|
P NymarkH WikmanT Hienonen-KempasS
AnttilaMolecular and genetic changes in asbestos-related lung
cancerCancer Lett265115200810.1016/j.canlet.2008.02.04318364247
|
|
32.
|
J SanceauJ WijdenesM RevelJ WietzerbinIL-6
and IL-6 receptor modulation by IFN-gamma and tumor necrosis
factor-alpha in human monocytic cell line (THP-1). Priming effect
of IFN-gammaJ Immunol1472630263719911918983
|
|
33.
|
F HuauxM ArrasA VinkJC RenauldD
LisonSoluble tumor necrosis factor (TNF) receptors p55 and p75 and
inter-leukin-10 downregulate TNF-alpha activity during the lung
response to silica particles in NMRI miceAm J Respir Cell Mol
Biol21137145199910.1165/ajrcmb.21.1.357010385602
|
|
34.
|
S HelmigN AliahmadiJ SchneiderTumour
necrosis factor-alpha gene polymorphisms in asbestos-induced
diseasesBiomarkers15400409201010.3109/1354750X.2010.48136520486865
|
|
35.
|
S HelmigA BelweJ SchneiderAssociation of
transforming growth factor beta1 gene polymorphisms and
asbestos-induced fibrosis and tumorsJ Investig
Med57655661200919349911
|
|
36.
|
B YucesoyV VallyathanDP LandsittelP
SimeonovaMI LusterCytokine polymorphisms in silicosis and other
pneumoconiosesMol Cell Biochem234–235219224200212162437
|
|
37.
|
C KiyoharaT HoriuchiK TakayamaY
NakanishiIL1B rs1143634 polymorphism, cigarette smoking, alcohol
use, and lung cancer risk in a Japanese populationJ Thorac
Oncol5299304201010.1097/JTO.0b013e3181c8cae320035239
|
|
38.
|
DA PapanicolaouRL WilderSC ManolagasGP
ChrousosThe pathophysiologic roles of interleukin-6 in human
diseaseAnn Intern
Med128127137199810.7326/0003-4819-128-2-199801150-000099441573
|
|
39.
|
B SchluterC RaufhakeM ErrenEffect of the
interleukin-6 promoter polymorphism (−174 G/C) on the incidence and
outcome of sepsisCrit Care Med3032372002
|
|
40.
|
I AtesHS SuzenB YucesoyIO TekinA
KarakayaAssociation of cytokine gene polymorphisms in CWP and its
severity in Turkish coal workersAm J Ind
Med51741747200810.1002/ajim.2063218702109
|
|
41.
|
DM TurnerDM WilliamsD SankaranM LazarusPJ
SinnottIV HutchinsonAn investigation of polymorphism in the
interleukin-10 gene promoterEur J
Immunogenet2418199710.1111/j.1365-2370.1997.tb00001.x9043871
|
|
42.
|
AR TamburJW OrtegelZ Ben-AriRole of
cytokine gene polymorphism in hepatitis C recurrence and allograft
rejection among liver transplant
recipientsTransplantation7114751480200110.1097/00007890-200105270-0002011391238
|
|
43.
|
C PerreyV PravicaPJ SinnottIV
HutchinsonGenotyping for polymorphisms in interferon-gamma,
interleukin-10, transforming growth factor-beta 1 and tumour
necrosis factor-alpha genes: a technical reportTranspl
Immunol6193197199810.1016/S0966-3274(98)80045-29848226
|
|
44.
|
C SeifartA PlagensA DempfleTNF-alpha,
TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung
cancerDis Markers21157165200510.1155/2005/70713116276011
|
|
45.
|
CM ShihYL LeeHL ChiouThe involvement of
genetic polymorphism of IL-10 promoter in non-small cell lung
cancerLung
Cancer50291297200510.1016/j.lungcan.2005.07.00716122836
|
|
46.
|
Y ZhouW HuW ZhuangX WuInterleukin-10 −1082
promoter polymorphism and gastric cancer risk in a Chinese Han
populationMol Cell Biochem34789932010
|
|
47.
|
EK SilvermanLJ PalmerCase-control
association studies for the genetics of complex respiratory
diseasesAm J Respir Cell Mol
Biol22645648200010.1165/ajrcmb.22.6.f19110837359
|
|
48.
|
J ParkerRadiological criteria: the use of
chest imaging techniques in asbestos-related diseasesProceedings of
an International Expert Meeting on Asbestos, Asbestosis and Cancer,
People and Work, Research ReportsFinnish Institute of Occupational
HealthHelsinki28401997
|
|
49.
|
P DeVuystGuidelines for attribution of
lung cancer to asbestosProceedings of an International Expert
Meeting on Asbestos, Asbestosis and Cancer, People and Work,
Research ReportsFinnish Institute of Occupational
HealthHelsinki92961997
|
